Ronald T. Gansevoort

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

First Morning Voids Are More Reliable Than Spot Urine Samples to Assess Microalbuminuria

Elsbeth C. Witte, Hiddo J.L. Heerspink, Dick de Zeeuw et al. · Journal of the American Society of Nephrology · 2008 · 282 citations

Medicine, Nephrology, Urology +15

Macroalbuminuria Is a Better Risk Marker than Low Estimated GFR to Identify Individuals at Risk for Accelerated GFR Loss in Population Screening

Nynke Halbesma, Dirk-Sjoerd Kuiken, Auke H. Brantsma et al. · Journal of the American Society of Nephrology · 2006 · 206 citations

Medicine, Nephrology, Early Detection +16

Screening for Albuminuria Identifies Individuals at Increased Renal Risk

Marije van der Velde, Nynke Halbesma, Frank de Charro et al. · Journal of the American Society of Nephrology · 2009 · 152 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Gender differences in predictors of the decline of renal function in the general population

Nynke Halbesma, Auke H. Brantsma, Stephan J. L. Bakker et al. · Kidney International · 2008 · 151 citations · Full text

Medicine, Nephrology, Renal Pathophysiology +13